I obtained my degree in Biomolecular Engineering from the Technical University of Darmstadt and earned my PhD at the German Cancer Research Center, in collaboration with the Heidelberg University Hospital, supported by the José Carreras Leukemia Foundation and the Flagship Initiative Engineering Molecular Systems.
My scientific expertise lies in the characterization and development of advanced cancer immunotherapies, including T cell therapies and antibody-drug conjugates, with a particular focus on the establishment of single-cell interaction experiments. In the field of translational research, my work has been dedicated to advancing treatment strategies for patients with hematological malignancies including multiple myeloma, acute myeloid leukemia (AML), and chronic lymphocytic leukemia (CLL).
Beyond my research, I enjoy playing the piano, engaging in sports, traveling, and scuba diving.